--Lonza has chosen U.S. investment banks Bank of America and Centerview Partners to oversee the sale of its capsules business, as the Swiss drug manufacturer attempts to streamline its business, Bloomberg Law reported, citing unnamed sources.
--The deal could be worth at least 2.5 billion euros ($2.62 billion) but details of the transaction could still change, according to one source, the report said.
Full story: https://bit.ly/40XJe9g
Write to Helena Smolak at helena.smolak@wsj.com
(END) Dow Jones Newswires
February 18, 2025 07:07 ET (12:07 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.